Clinical Trials Directory

Trials / Terminated

TerminatedNCT03261388

Activity Based Locomotor Exercise PrOgram-Wait-list controllEd Research

ABLE POWER - Activity Based Locomotor Exercise PrOgram: Wait-list controllEd Research

Status
Terminated
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Allina Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

At Courage Kenny Rehabilitation Institute, rehabilitation for individuals with spinal cord injury (SCI) is being led by the NIH funded NeuroRecovery Network (NRN) Community Fitness and Wellness Program through the Activity-Based Locomotor Exercise Program (ABLE). Any individual with a spinal cord injury who is eligible for the ABLE Program is eligible for participation in the NeuroRecovery Network Research Project (NRN). The purpose of the ABLE POWER Study is to evaluate the effectiveness of activity-based locomotor exercise programs in individuals with SCI through a wait-list controlled design. Individuals who have a spinal cord injury and are on the wait list for ABLE will be enrolled in this project for a year while they wait for an opening in the ABLE program. Changes that occur while participants are on the wait list will be compared to changes that occur after they are enrolled in ABLE. A difference in the rate of improvement after enrollment in the intervention would be attributed to the ABLE intervention. Individuals participating in the ABLE program will receive the ABLE intervention regardless of participation in the ABLE POWER research study. In this design, there will be two measures in the year prior to enrollment in ABLE, and two measures in the year after enrollment, and the two time periods would be compared to the data collected at enrollment into ABLE.

Conditions

Interventions

TypeNameDescription
BEHAVIORALActivity-Based Locomotor Exercise Program (ABLE)The ABLE program is an intensive locomotor based intervention that is offered at the Golden Valley Courage Kenny Rehabilitation Institute.

Timeline

Start date
2016-11-07
Primary completion
2020-01-21
Completion
2020-01-21
First posted
2017-08-25
Last updated
2020-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03261388. Inclusion in this directory is not an endorsement.